Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentijn Vergote

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 22, 2019
Molecular epidemiology, phylogenetic analysis and genotype distribution of hepatitis B virus in Saudi Arabia: Predominance of genotype D1Ahmed A Al-Qahtani, Mahmoud Reza Pourkarim, Nídia Sequeira Trovão, et al.
Regulatory Peptides|May 9, 2009
Central administration of obestatin fails to show inhibitory effects on food and water intake in miceAnnemie Van Dijck, Van Dijck Annemie, Debby Van Dam, et al.
British Journal of Haematology|December 14, 2020
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodiesAlbrecht Betrains, Laurent Godinas, F J Sherida H Woei-A-Jin, et al.
Ebiomedicine|September 27, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection modelRana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Genome Biology and Evolution|December 23, 2017
A Novel Hantavirus of the European Mole, Bruges Virus, Is Involved in Frequent Nova Virus CoinfectionsLies Laenen, Valentijn Vergote, Liana Eleni Kafetzopoulou, et al.
Emerging Infectious Diseases|December 22, 2020
Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease OutcomesTony Wawina-Bokalanga, Bert Vanmechelen, Valentine Lhermitte, et al.
Antiviral Research|April 7, 2022
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effectCaroline S Foo, Rana Abdelnabi, Suzanne J F Kaptein, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activitySuzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
The Lancet. Infectious Diseases|October 16, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort studyRuth Thom, Thomas Tipton, Thomas Strecker, et al.
Nature Communications|November 18, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamstersRobbert Boudewijns, Hendrik Jan Thibaut, Suzanne J F Kaptein, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 22, 2019
Molecular epidemiology, phylogenetic analysis and genotype distribution of hepatitis B virus in Saudi Arabia: Predominance of genotype D1Ahmed A Al-Qahtani, Mahmoud Reza Pourkarim, Nídia Sequeira Trovão, et al.
Regulatory Peptides|May 9, 2009
Central administration of obestatin fails to show inhibitory effects on food and water intake in miceAnnemie Van Dijck, Van Dijck Annemie, Debby Van Dam, et al.
British Journal of Haematology|December 14, 2020
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodiesAlbrecht Betrains, Laurent Godinas, F J Sherida H Woei-A-Jin, et al.
Ebiomedicine|September 27, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection modelRana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Genome Biology and Evolution|December 23, 2017
A Novel Hantavirus of the European Mole, Bruges Virus, Is Involved in Frequent Nova Virus CoinfectionsLies Laenen, Valentijn Vergote, Liana Eleni Kafetzopoulou, et al.
Emerging Infectious Diseases|December 22, 2020
Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease OutcomesTony Wawina-Bokalanga, Bert Vanmechelen, Valentine Lhermitte, et al.
Antiviral Research|April 7, 2022
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effectCaroline S Foo, Rana Abdelnabi, Suzanne J F Kaptein, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activitySuzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
The Lancet. Infectious Diseases|October 16, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort studyRuth Thom, Thomas Tipton, Thomas Strecker, et al.
Nature Communications|November 18, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamstersRobbert Boudewijns, Hendrik Jan Thibaut, Suzanne J F Kaptein, et al.
Pageof 5